Understanding the biological effects of SARS-CoV-2 persistence in children

FHS
June 29, 2023
7:33 am

Researchers analyzed the most recent knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

BeiGene licenses solid tumor drug, matches with Ideaya’s combo plans

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 14, 2024

Monkeypox mimics smallpox vaccine’s immune response, new study reveals

The study in Nature Communications reveals that MPOX infection triggers an anti-viral antibody response akin to that from smallpox vaccination. Utilizing a comprehensive array of

September 26, 2023

EU Allocates €6.5M for Psychedelic Study

The TDR Three Key Takeaways: 1. The EU €6.5 million investment in the PsyPal trial marks its first foray into funding psychedelic therapy research, aiming

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.